USPTO serial 75142552
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Don M. Kerr
G MATHEW LOMBARD BRISTOL-MYERS SQUIBB COMPANY345 PARK AVENEW YORK, NY 10154UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations, for the treatment of cardiovascular diseases, central nervous system diseases, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases and for diagnostic imaging | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 24, 2002 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 12, 1997 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Mar 7, 1997 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Feb 18, 1997 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 17, 1997 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 14, 1996 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 24, 1996 | DOCK | ASSIGNED TO EXAMINER | — |